Maky Zanganeh, COO at Pharmacyclics, holds 25.49M shares in Summit Therapeutics (Ticker: SMMT), holds 752.99K shares in Pulse Biosciences (Ticker: PLSE), holds 0.00 shares in Pharmacyclics (Ticker: PCYC). Most recently, Maky Zanganeh Bought ― shares of Summit Therapeutics on Mar 27, 2024 for an estimated value of 411.09K.